The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

The vaccine is manufactured at Valneva’s leading vaccine production site in Livingston, Scotland. The approval is based on IXCHIQ ® ’s final pivotal Phase 3 data, published in The Lancet ...

The vaccine is manufactured at Valneva’s leading vaccine production site in Livingston, Scotland. The approval is based on IXCHIQ®’s final pivotal Phase 3 data, published in The Lancet ...

UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...

Gregor Poynton was speaking after it was revealed £4 million has already been invested in key projects in the constituency, ...

Valneva manufactures the shot at its facility in Livingston, Scotland. The reimbursement deal follows a similar agreement, unveiled last summer, for the drug in patients with transfusion-dependent ...

Valneva USA Inc.,* Bethesda ... This is a one-year contract with no option periods. Location of performance is Scotland, with a Jan. 28, 2026, ordering period end date. Using customers are Army, Navy, ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), allowing the single-dose vaccine to be made available for adults ...